by Nature
Building on the success of their T-cell receptor-mimic antibody (TCR-m) targeting the signal peptide CG1, scientists applied a similar construct to the development of chimeric antigen receptor...
by Blood
Research confirms the contribution of CD47 upregulation to the development of graft-versus-host disease (GVHD) following allogeneic hematopoietic cell transplantation (allo-HCT) and supports...
by Nature
Evidence suggests that adding both a calcineurin inhibitor (CNI) and mycophenolate mofetil (MMF) to post-transplant cyclophosphamide (PTCy) may help prevent a common complication after HLA-matched...
by Blood Advances
Registry data suggest post-transplant cyclophosphamide (PTCy) is safe and effective for patients with severe aplastic anemia (SAA) who undergo stem cell transplantation (SCT), especially with...
This webinar will discuss the role of non-Aspergillus mold infections (NAIMIs) in hematopoietic cell transplantation (HCT) recipients.
This interactive webinar will highlight key research abstracts featured at the 2025 Tandem Meetings of ASTCT and CIBMTR.